🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The 6th Annual Cedars-Sinai #Gastrointestinal #Tumor Conference will be held on 4/5. The event will cover the latest updates on #GI #cancer therapies, including #precisionmedicine, #immunotherapy, and #biomarkers. bit.ly/3Zes72i

AACR members have elected five members of the AACR Board of Directors for the 2025-2028 term. Congratulations to Johann S. de Bono, MD, PhD, Mikala Egeblad, PhD, Crystal L. Mackall, MD, FAACR, Charles W.M. Roberts, MD, PhD, and Timothy A. Yap, MBBS, PhD. brnw.ch/21wRARe

The website for our new California Institute for Regenerative Medicine Organoid and Organ-Chip Shared Resources Lab at Regenerative Medicine Institute at Cedars-Sinai is now live! We offer training, services, and shared equipment to support stem cell researchers across California. Take a look!🔬🧫 cedars-sinai.edu/health-science…

how do you feel?: cnn.com/2025/04/09/hea…

Our latest paper demonstrating the potential of “our” DOT cells against colorectal cancer has just been published in Nature Cancer: rdcu.be/ehYwG Many congrats to the whole team, especially Rafa Blanco Domínguez! :)

🔥Smoking hot new paper and tweetorial from Caleb Cheng (collab with Arul Chinnaiyan)! 🔥 We are over the moon about this new work and its therapeutic implications for pancreatic cancer. Please have a read and share your thoughts/feedback! 🙏🏼

Had tickets in 2020 in Philly but cancelled due to covid...and finally, most likely the best well rounded piano player of recent years! He really sounds like a boss

AACR Statement and Call to Action Regarding the Administration’s Recent Actions Affecting NIH and the American People aacr.org/nih

Dr. Sergey Grivennikov Sergei Grivennikov will co-chair the #AACR225 mini-symposium “#Cancer Models: Mechanisms and Therapies” taking place today at 2:30pm CT. AACR

Bye angel chagolla Chicago, hi Marine weather LA

Why do not we see you, Los Angeles?

Brian S. Kim This supposed "replication crisis" is almost entirely explained by sampling bias. I'm willing to post that the vast majority of biology IS reproducible. But you can't publish or get funding for reproducible, so even when you do it (we do ALL the time), you quickly pivot

Super happy to share our latest in Nature Cancer co-led by Nick Pannunzio! We review the complex role of the circadian clock in genome integrity, DNA repair, immunity, metabolism, and cancer with a specific focus on early-onset cancer. Check it out! nature.com/articles/s4301…

Foamy macrophages aren’t just bystanders in atherosclerosis. They may hold the key to controlling inflammation. Check out this new review from Marco Orecchioni & team Frontiers: frontiersin.org/journals/cardi…

“By identifying the inventors of drugs approved by the Food and Drug Administration (and the key patents curated in the FDA Orange Book), our review revealed that from 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. Even more stunningly, 87%

ASH Bridge Award direct cost floor was already raised to $500K/yr. Now the number of applications funded is dramatically increasing, with a rapid turn around...and a brand new additional cycle this year. ASH

🎉 Excited to share our new publication in Cell Reports Medicine! 🙌 Big thanks to our amazing collaborators! 📄 lnkd.in/grHHDkKB #LiquidBiopsy #Oncosomes #EVresearch #RNASeq #CancerBiology #CellReportsMedicine

Out today from ThePerryLab, our work suggesting how exposure to high fructose in pregnant mice or developing neonates directly affects neurodevelopment. In nature nature.com/articles/s4158… Memorial Sloan Kettering Cancer Center Weill Cornell Medicine funded by NIH NIH Common Fund cc: Jay Bhattacharya, MD, PhD

We’re thrilled to welcome Dr. Carla Rothlin(carla rothlin) as our new Director of the Center for Immunology and Dr. Sourav Ghosh as CFI Program director, Immunology of Tissue Resolution, Repair, & Regeneration at UMN! Both join us from Yale and officially start in August 2025.

tumor related inflammation! and microbial traces